PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study.

Autor:	Vogel, Arndt1 vogela@me.com, Kasper, Stefan2, Bitzer, Michael3, Block, Andreas4, Sinn, Marianne5, Schulze-Bergkamen, Henning6, Moehler, Markus7, Pfarr, Nicole8,9, Endris, Volker8, Goeppert, Benjamin8, Merx, Kirsten10, Schnoy, Elisabeth11, Siveke, Jens T.12, Michl, Patrick13, Waldschmidt, Dirk14, Kuhlmann, Jan15, Geissler, Michael16, Kahl, Christoph17, Evenkamp, Ralph18, Schmidt, Torben19
Zdroj:	European Journal of Cancer. Mar2018, Vol. 92, p11-19. 9p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect